UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 696

Sortiert nach

Stat3 Activation in Urothelial Stem Cells Leads to Direct Progression to Invasive Bladder Cancer

Cancer research (Chicago, Ill.), 2012-07, Vol.72 (13), p.3135-3142

2012

Volltextzugriff (PDF)

Targeting Mammalian Target of Rapamycin Synergistically Enhances Chemotherapy-Induced Cytotoxicity in Breast Cancer Cells

Clinical cancer research, 2004-10, Vol.10 (20), p.7031-7042

2004

Volltextzugriff (PDF)

Sunitinib malate is active against human urothelial carcinoma and enhances the activity of cisplatin in a preclinical model

Urologic oncology, 2009-07, Vol.27 (4), p.391-399

2009

Volltextzugriff (PDF)

Determinants of Rapamycin Sensitivity in Breast Cancer Cells

Clinical cancer research, 2004-02, Vol.10 (3), p.1013-1023

2004

Volltextzugriff (PDF)

Efficacy of Selective Estrogen Receptor Modulators in Nude Mice Bearing Human Transitional Cell Carcinoma

Urology (Ridgewood, N.J.), 2007-06, Vol.69 (6), p.1221-1226

2007

Volltextzugriff (PDF)

Enzastaurin shows preclinical antitumor activity against human transitional cell carcinoma and enhances the activity of gemcitabine

Molecular cancer therapeutics, 2009-07, Vol.8 (7), p.1772-1778

2009

Volltextzugriff (PDF)

Correlation of Cyclooxygenase-2 Expression With Molecular Markers, Pathological Features and Clinical Outcome of Transitional Cell Carcinoma of the Bladder

The Journal of urology, 2003-09, Vol.170 (3), p.985-989

2003

Volltextzugriff (PDF)

A conventional preclinical schedule of cisplatin is more effective than a metronomic frequent bolus schedule for urothelial carcinoma

Urologic oncology, 2013-02, Vol.31 (2), p.234-240

2013

Volltextzugriff (PDF)

Urinary Levels of Soluble E-Cadherin in the Detection of Transitional Cell Carcinoma of the Urinary Bladder

European urology, 2005-07, Vol.48 (1), p.69-76

2005

Volltextzugriff (PDF)

Positive association of collagen type I with non-muscle invasive bladder cancer progression

Oncotarget, 2016-12, Vol.7 (50), p.82609-82619

2016

Volltextzugriff (PDF)

CEP-11981, a small molecule inhibitor of multiple angiogenic targets, in a preclinical system of urothelial carcinoma (UC)

Journal of clinical oncology, 2013-02, Vol.31 (6_suppl), p.293-293

2013

Volltextzugriff (PDF)

Expression of estrogen receptors‐α and ‐β in bladder cancer cell lines and human bladder tumor tissue

Cancer, 2006-06, Vol.106 (12), p.2610-2616

2006

Volltextzugriff (PDF)

The angiopoietin-TIE2 pathway is a potential therapeutic target in urothelial carcinoma

Anticancer research, 2014-07, Vol.34 (7), p.3377

2014

Volltextzugriff (PDF)

The preclinical activity of lenalidomide in indolent urothelial carcinoma

Anticancer research, 2014-07, Vol.34 (7), p.3383-3389

2014

Volltextzugriff (PDF)

The preclinical anti-angiogenic and pro-apoptotic activity of lenalidomide in urothelial carcinoma (UC)

Journal of clinical oncology, 2013-02, Vol.31 (6_suppl), p.294-294

2013

Volltextzugriff (PDF)

Dasatinib is preclinically active against Src-overexpressing human transitional cell carcinoma of the urothelium with activated Src signaling

Molecular cancer therapeutics, 2010-05, Vol.9 (5), p.1128-1135

2010

Volltextzugriff (PDF)

The preclinical activity of lenalidomide in urothelial carcinoma (UC)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e15002-e15002

2012

Volltextzugriff (PDF)

Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen

Translational oncology, 2013-06, Vol.6 (3), p.244-255

2013

Volltextzugriff (PDF)

Activity of CEP-9722, a poly (ADP-ribose) polymerase inhibitor, in urothelial carcinoma correlates inversely with homologous recombination repair response to DNA damage

Anti-cancer drugs, 2014-09, Vol.25 (8), p.878-886

2014

Volltextzugriff (PDF)

Role of glycogen synthase kinase 3β in rapamycin-mediated cell cycle regulation and chemosensitivity

Cancer research (Chicago, Ill.), 2005-03, Vol.65 (5), p.1961-1972

2005

Volltextzugriff (PDF)

ONE-YEAR OUTCOME OF BLADDER AUGMENTATION WITH A NOVEL BIODEGRADABLE MATRIX IN A PORCINE MODEL

The Journal of urology, 2008, Vol.179 (4), p.76-76

2008

Volltextzugriff (PDF)

945. Combination Treatment of Adenovirus Mediated HSV-Thymidine Kinase Suicide Gene Therapy and Docetaxel in Bladder Cancer

Molecular therapy, 2006-05, Vol.13 (S1), p.S365-S365

2006

Volltextzugriff (PDF)

Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen1

Translational oncology, 2013-06, Vol.6 (3), p.244-255

2013

Volltextzugriff (PDF)

Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity

Cancer research (Chicago, Ill.), 2005-03, Vol.65 (5), p.1961-1972

2005

Volltextzugriff (PDF)

Expression of estrogen receptors-a and -β in bladder cancer cell lines and human bladder tumor tissue

Cancer, 2006, Vol.106 (12), p.2610-2616

2006

Volltextzugriff (PDF)

1 – 25 von 696

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(609)
Mit Volltextzugriff
(667)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(512)
Life Sciences & Biomedicine
(238)
Physical Sciences
(177)
Technology
(174)
Humans
(126)
Chemistry
(117)
Engineering
(91)
Materials Science
(79)
Female
(74)
Materials Science, Multidisciplinary
(68)
Science & Technology - Other Topics
(61)
Oncology
(56)
Male
(55)
Animals
(54)
Chemistry, Multidisciplinary
(53)
Physics
(48)
Middle Aged
(43)
Chemistry, Physical
(37)
Adult
(33)
Mice
(32)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Stat3 Activation in Urothelial Stem Cells Leads to Direct Progression to Invasive Bladder Cancer

Targeting Mammalian Target of Rapamycin Synergistically Enhances Chemotherapy-Induced Cytotoxicity in Breast Cancer Cells

Sunitinib malate is active against human urothelial carcinoma and enhances the activity of cisplatin in a preclinical model

Determinants of Rapamycin Sensitivity in Breast Cancer Cells

Efficacy of Selective Estrogen Receptor Modulators in Nude Mice Bearing Human Transitional Cell Carcinoma

Enzastaurin shows preclinical antitumor activity against human transitional cell carcinoma and enhances the activity of gemcitabine

Correlation of Cyclooxygenase-2 Expression With Molecular Markers, Pathological Features and Clinical Outcome of Transitional Cell Carcinoma of the Bladder

A conventional preclinical schedule of cisplatin is more effective than a metronomic frequent bolus schedule for urothelial carcinoma

Urinary Levels of Soluble E-Cadherin in the Detection of Transitional Cell Carcinoma of the Urinary Bladder

Positive association of collagen type I with non-muscle invasive bladder cancer progression

CEP-11981, a small molecule inhibitor of multiple angiogenic targets, in a preclinical system of urothelial carcinoma (UC)

Expression of estrogen receptors‐α and ‐β in bladder cancer cell lines and human bladder tumor tissue

The angiopoietin-TIE2 pathway is a potential therapeutic target in urothelial carcinoma

The preclinical activity of lenalidomide in indolent urothelial carcinoma

The preclinical anti-angiogenic and pro-apoptotic activity of lenalidomide in urothelial carcinoma (UC)

Dasatinib is preclinically active against Src-overexpressing human transitional cell carcinoma of the urothelium with activated Src signaling

The preclinical activity of lenalidomide in urothelial carcinoma (UC)

Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen

Activity of CEP-9722, a poly (ADP-ribose) polymerase inhibitor, in urothelial carcinoma correlates inversely with homologous recombination repair response to DNA damage

Role of glycogen synthase kinase 3β in rapamycin-mediated cell cycle regulation and chemosensitivity

ONE-YEAR OUTCOME OF BLADDER AUGMENTATION WITH A NOVEL BIODEGRADABLE MATRIX IN A PORCINE MODEL

945. Combination Treatment of Adenovirus Mediated HSV-Thymidine Kinase Suicide Gene Therapy and Docetaxel in Bladder Cancer

Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen1

Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity

Expression of estrogen receptors-a and -β in bladder cancer cell lines and human bladder tumor tissue

Suchergebnisse filtern